{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:09:35Z","timestamp":1791461375915,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173843"],"award-info":[{"award-number":["82173843"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Science Advances"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pscia.2024.100057","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T10:38:29Z","timestamp":1731235109000},"page":"100057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Quercetin inhibits malignant progression of high metastatic advanced colon cancer in hypoxia via suppressing ROS and PI3K\/AKT pathway"],"prefix":"10.1016","volume":"2","author":[{"given":"Pengfei","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.pscia.2024.100057_bib1","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1097\/CM9.0000000000001076","article-title":"Current status of surgical treatment of rectal cancer in China","volume":"133","author":"Yang","year":"2020","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.pscia.2024.100057_bib2","first-page":"24","article-title":"[Improvement of prognostic and predictive network of colorectal cancer based upon the 8th edition of AJCC colorectal cancer staging system]","volume":"20","author":"Yao","year":"2017","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"3","key":"10.1016\/j.pscia.2024.100057_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00432-018-2795-1","article-title":"Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)","volume":"145","author":"Xu","year":"2019","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.pscia.2024.100057_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40880-019-0377-5","article-title":"Modelling the probability of erroneous negative lymph node staging in patients with colon cancer","volume":"39","author":"Fortea-Sanchis","year":"2019","journal-title":"Cancer Commun."},{"issue":"10","key":"10.1016\/j.pscia.2024.100057_bib5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/gut.2010.211557","article-title":"Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study","volume":"59","author":"Mitry","year":"2010","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.pscia.2024.100057_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ctrv.2015.06.006","article-title":"Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus","volume":"41","author":"Adam","year":"2015","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.pscia.2024.100057_bib7","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2147\/CMAR.S163520","article-title":"Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection","volume":"10","author":"Peng","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"11","key":"10.1016\/j.pscia.2024.100057_bib8","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/annonc\/mdw404","article-title":"Phase III trial comparing 3-6 months of adjuvant FOLFOX4\/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial","volume":"27","author":"Lonardi","year":"2016","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.pscia.2024.100057_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2017.04.017","article-title":"Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells","volume":"153","author":"Li","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pscia.2024.100057_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.pscia.2024.100057_bib11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/1535370220934038","article-title":"Hypoxic tumor microenvironment: implications for cancer therapy","volume":"245","author":"Roy","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"11","key":"10.1016\/j.pscia.2024.100057_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100845","article-title":"Hypoxia, partial EMT and collective migration: emerging culprits in metastasis","volume":"13","author":"Saxena","year":"2020","journal-title":"Transl Oncol"},{"key":"10.1016\/j.pscia.2024.100057_bib13","article-title":"IvanaSimin, NatasaPintac, DiandraMajkic, TatjanaBekvalac, KristinaOrcic, DejanMimica-dukic, neda, antioxidant and anti-inflammatory activities of quercetin and its derivatives","volume":"40","author":"Lesjak","year":"2018","journal-title":"J.\u00a0Funct.Foods"},{"key":"10.1016\/j.pscia.2024.100057_bib14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.biopha.2018.10.130","article-title":"In vitro and in vivo evidence that quercetin protects against diabetes and its complications: a systematic review of the literature","volume":"109","author":"Shi","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.pscia.2024.100057_bib15","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1002\/jcp.26595","article-title":"Quercetin: a functional dietary flavonoid with potential chemo-preventive properties in colorectal cancer","volume":"233","author":"Darband","year":"2018","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.pscia.2024.100057_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108303","article-title":"The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment","volume":"240","author":"Wang","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.pscia.2024.100057_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pscia.2024.100057_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109604","article-title":"Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects","volume":"121","author":"Tang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.pscia.2024.100057_bib19","article-title":"HIF-1\u03b1 promotes epithelial-mesenchymal transition and metastasis through direct regulation of ZEB1 in colorectal cancer","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.pscia.2024.100057_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/15680096113136660102","article-title":"The role of snail in EMT and tumorigenesis","volume":"13","author":"Wang","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.pscia.2024.100057_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.pscia.2024.100057_bib22","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.7150\/ijbs.66854","article-title":"SNAIL induces EMT and lung metastasis of tumours secreting CXCL2 to promote the invasion of M2-type immunosuppressed macrophages in colorectal cancer","volume":"18","author":"Bao","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.pscia.2024.100057_bib23","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1111\/jcmm.14276","article-title":"Targeting the ROS\/PI3K\/AKT\/HIF-1\u03b1\/HK2 axis of breast cancer cells: combined administration of Polydatin and 2-Deoxy-d-glucose","volume":"23","author":"Zhang","year":"2019","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.pscia.2024.100057_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/srep24049","article-title":"Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis","volume":"6","author":"Srivastava","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.pscia.2024.100057_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10495-014-0967-2","article-title":"Autophagy and apoptosis: where do they meet?","volume":"19","author":"Mukhopadhyay","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.pscia.2024.100057_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","article-title":"Regulation mechanisms and signaling pathways of autophagy","volume":"43","author":"He","year":"2009","journal-title":"Annu. Rev. Genet."},{"issue":"2","key":"10.1016\/j.pscia.2024.100057_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020135","article-title":"Autophagy: mechanisms and therapeutic potential of flavonoids in cancer","volume":"11","author":"Pang","year":"2021","journal-title":"Biomolecules"}],"container-title":["Pharmaceutical Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773216924000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773216924000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:55:40Z","timestamp":1733468140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773216924000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"alternative-id":["S2773216924000230"],"URL":"https:\/\/doi.org\/10.1016\/j.pscia.2024.100057","relation":{},"ISSN":["2773-2169"],"issn-type":[{"value":"2773-2169","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quercetin inhibits malignant progression of high metastatic advanced colon cancer in hypoxia via suppressing ROS and PI3K\/AKT pathway","name":"articletitle","label":"Article Title"},{"value":"Pharmaceutical Science Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscia.2024.100057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Shandong University.","name":"copyright","label":"Copyright"}],"article-number":"100057"}}